- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 143 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 100 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 112 Pages
North America
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 85 Pages
North America
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 90 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 70 Pages
Africa, Middle East
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 150 Pages
North America
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 70 Pages
South Korea
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 70 Pages
Spain
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 110 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- October 2022
- 70 Pages
Africa
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2020
- 150 Pages
Global
From €3868EUR$4,250USD£3,285GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- August 2018
- 154 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Report
- October 2020
- 133 Pages
Global
From €13648EUR$14,995USD£11,592GBP
- Clinical Trials
- October 2020
- 192 Pages
Global
From €2275EUR$2,500USD£1,933GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more